Binding of vinblastine and estramustine to isolated plasma membrane fractions from human prostate and prostatic tumors
- 10 September 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 106 (2), 217-220
- https://doi.org/10.1016/0304-3835(96)04321-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Characterisation of muscarinic cholinergic receptors in human ovaries, ovarian tumours and tumour cell linesEuropean Journal Of Cancer, 1993
- Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.Journal of Clinical Oncology, 1992
- Estramustine and Vinblastine: Use of Prostate Specific Antigen as a Clinical Trial End Point for Hormone Refractory Prostatic CancerJournal of Urology, 1992
- Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.The Journal of cell biology, 1988
- A simplification of the protein assay method of Lowry et al. which is more generally applicableAnalytical Biochemistry, 1977